Bioymifi
产品编号: DC7603
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
Bioymifi是第一个新型TRAIL受体DR5小分子激动剂。
| Cas No.: |
1420071-30-2 |
| 名称: |
(Z)-5-(5-((3-(4-bromophenyl)-2-imino-4-oxothiazolidin-5-ylidene)methyl)furan-2-yl)isoindoline-1,3-dione |
| 别名: |
(DR5 Activator) |
| SMILES: |
C1=CC(=CC=C1N2C(=O)/C(=C/C3=CC=C(O3)C4=CC5=C(C=C4)C(=O)NC5=O)/SC2=N)Br |
| 分子式: |
C22H12BrN3O4S |
| 分子量: |
494.32 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Bioymifi(DR5 Activator) is the first novel and potent small-molecule activatior of the TRAIL receptor DR5 in human cancer cells. IC50 value: Target: In comparison with A2C2, bioymifi was able to promote cell death without the need For the Smac mimetic in |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
| TITLE |
DOWNLOAD |
| MSDS_1848_DC7603_1420071-30-2 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
询盘
